We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can KT&G Alliance Drive Altria's Next Global Growth Phase?
Read MoreHide Full Article
Key Takeaways
MO and KT&G recently signed an MOU to explore global opportunities in modern oral nicotine products.
The partnership may expand Altria's on! pouch brand and includes a stake in Another Snus Factory.
Collaboration leverages KT&G's global reach and supports Altria's smoke-free growth strategy.
Altria Group, Inc.’s ((MO - Free Report) ) recently announced alliance with KT&G marks a meaningful step in its push to expand beyond the U.S. market. The memorandum of understanding (“MOU”) creates a framework for the two companies to jointly explore international opportunities in modern oral nicotine products, including the potential expansion of Altria’s on! nicotine pouch portfolio into select global markets.
As part of the collaboration, Altria will also acquire an ownership interest in Another Snus Factory, the maker of the LOOP nicotine pouch brand, to broaden product offerings and appeal to consumers in regions where complex flavor profiles are driving growth.
The partnership allows Altria to leverage KT&G’s established global infrastructure and product development expertise while contributing its own strengths in commercialization, regulatory engagement and brand management. Beyond nicotine, the companies are also evaluating opportunities in U.S. non-nicotine products through KT&G’s Korea Ginseng Corporation and assessing potential operational efficiencies in traditional tobacco manufacturing and supply-chain functions.
While the alliance currently remains in a non-binding stage, it reflects a deliberate step toward expanding Altria’s presence in smoke-free categories internationally. The global modern oral market continues to grow rapidly, and collaboration with KT&G could accelerate Altria’s participation by providing access to established distribution networks and product platforms.
Successful execution of the partnership will be key, as Altria seeks to strengthen its position in next-generation products and further the long-term goal of transitioning toward a smoke-free future.
Where PM and TPB Stand Next to Altria
Philip Morris International Inc. ((PM - Free Report) ) continues to set the global standard in the smoke-free transition, with smoke-free products contributing 41% of net revenues in the third quarter of 2025. Its nicotine pouch brand, ZYN, maintained strong momentum in the United States, delivering 39% offtake growth according to Nielsen data, while Philip Morris’ broader smoke-free portfolio now spans 100 international markets. Philip Morris’ emphasis on category leadership, regulatory readiness and large-scale commercialization reflects its deep investment in next-generation nicotine formats.
Turning Point Brands, Inc. ((TPB - Free Report) ) continues to accelerate growth through its expanding Modern Oral portfolio, which now represents nearly one-third of sales. In the third quarter of 2025, Turning Point Brands’ revenues rose 31.2% year over year to $119 million, and Modern Oral's net sales surged 627.6% to $36.7 million. Backed by strong margins and upcoming U.S. manufacturing capacity, Turning Point Brands is solidifying its position as a fast-scaling player in the high-growth modern oral category.
Altria’s Price Performance, Valuation & Estimates
Shares of Altria have lost 12.8% in the past month compared with the industry’s decline of 4%.
Image Source: Zacks Investment Research
From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 10.46X, down from the industry’s average of 14.07X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MO’s 2025 and 2026 earnings implies year-over-year growth of 6.1% and 2.5%, respectively.
Image: Bigstock
Can KT&G Alliance Drive Altria's Next Global Growth Phase?
Key Takeaways
Altria Group, Inc.’s ((MO - Free Report) ) recently announced alliance with KT&G marks a meaningful step in its push to expand beyond the U.S. market. The memorandum of understanding (“MOU”) creates a framework for the two companies to jointly explore international opportunities in modern oral nicotine products, including the potential expansion of Altria’s on! nicotine pouch portfolio into select global markets.
As part of the collaboration, Altria will also acquire an ownership interest in Another Snus Factory, the maker of the LOOP nicotine pouch brand, to broaden product offerings and appeal to consumers in regions where complex flavor profiles are driving growth.
The partnership allows Altria to leverage KT&G’s established global infrastructure and product development expertise while contributing its own strengths in commercialization, regulatory engagement and brand management. Beyond nicotine, the companies are also evaluating opportunities in U.S. non-nicotine products through KT&G’s Korea Ginseng Corporation and assessing potential operational efficiencies in traditional tobacco manufacturing and supply-chain functions.
While the alliance currently remains in a non-binding stage, it reflects a deliberate step toward expanding Altria’s presence in smoke-free categories internationally. The global modern oral market continues to grow rapidly, and collaboration with KT&G could accelerate Altria’s participation by providing access to established distribution networks and product platforms.
Successful execution of the partnership will be key, as Altria seeks to strengthen its position in next-generation products and further the long-term goal of transitioning toward a smoke-free future.
Where PM and TPB Stand Next to Altria
Philip Morris International Inc. ((PM - Free Report) ) continues to set the global standard in the smoke-free transition, with smoke-free products contributing 41% of net revenues in the third quarter of 2025. Its nicotine pouch brand, ZYN, maintained strong momentum in the United States, delivering 39% offtake growth according to Nielsen data, while Philip Morris’ broader smoke-free portfolio now spans 100 international markets. Philip Morris’ emphasis on category leadership, regulatory readiness and large-scale commercialization reflects its deep investment in next-generation nicotine formats.
Turning Point Brands, Inc. ((TPB - Free Report) ) continues to accelerate growth through its expanding Modern Oral portfolio, which now represents nearly one-third of sales. In the third quarter of 2025, Turning Point Brands’ revenues rose 31.2% year over year to $119 million, and Modern Oral's net sales surged 627.6% to $36.7 million. Backed by strong margins and upcoming U.S. manufacturing capacity, Turning Point Brands is solidifying its position as a fast-scaling player in the high-growth modern oral category.
Altria’s Price Performance, Valuation & Estimates
Shares of Altria have lost 12.8% in the past month compared with the industry’s decline of 4%.
Image Source: Zacks Investment Research
From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 10.46X, down from the industry’s average of 14.07X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MO’s 2025 and 2026 earnings implies year-over-year growth of 6.1% and 2.5%, respectively.
Image Source: Zacks Investment Research
Altria currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.